Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10
Continue Reading World Economic Forum Releases Top 10 Emerging Technologies of 2020
Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence
At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have
Continue Reading USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence
Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic
Ryder Launches $50M Venture Fund for Supply Chain Startups
This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.
The fund seeks to
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups
Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+
University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells
Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents
Scribe Enters CRISPR-Based Collaboration with Biogen
On October 7, 2020, Scribe Therapeutics announced a collaboration with Biogen, to collaborate on CRISPR-based medicines for treating neurological
Continue Reading Scribe Enters CRISPR-Based Collaboration with Biogen
Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round
French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will
Continue Reading Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round